Cite

    Charng, J. et al. (2021). Increased interdigitation zone visibility on optical coherence tomography following systemic fibroblast growth factor receptor 1‐3 tyrosine kinase inhibitor anticancer therapy. Clinical & experimental ophthalmology. pp. 579-590. [Online].